If the
rebound rode on growth stocks and reopening boosted value plays, vaccination is
set to prop up services 
The two
other catalysts, both in January 2020, were the thawing of the two-year-long
US-China tariff tiff, with the phase 1 trade agreement, and the UK formally leaving
the European Union, three-and-a-half years after a referendum. A deal for an
orderly exit was finalised before the year-end deadline. The transition to BS
VI norms from April 2020 cleared another overhang since 2016, contributing to spurring
consumption and investment that had got stalled in FY 2020.  If MSMEs were able to tap low interest rates,
institutional investors were snapping the downsized shares of large and medium
corporations. The decline in input and overhead costs provided flexibility to
deleverage, strengthening the balance sheet for funding growth. Tinkering the
output mix towards premium products increased realization. Establishing a
digital presence offset the drop in physical footfalls. Besides the need to
meet higher usage, the coverage of production-linked incentives encouraged many
companies to look for ramping up capacity as utilization touched the optimum
level.  Gains made their way from growth
to value counters, punctuating the market’s overheating. A vibrant primary
market signalled risk-taking.
If the
escalating benchmarks foretold Corporate India getting into shape, their
current movements offer hints of outlook. The Nifty P/E has slowed to around 29
from a high of 41 mid- February. Apart from spurt in earnings, the contraction
in the premium over the historical average of about 22 suggests a slower pace
of returns as raw materials turn expensive and logistics issues persist. The
Nifty IT index lagged over the past month on fears of recoiling inflation
leading to tapering of prime pumping in the US and the EU, the major markets.
The Nifty Auto index’s outperformance, despite down from its peak, captures the
struggle to obtain chips as well as hopes of CVs catching up with PVs and
two-wheelers on normalcy. Tie-ups to churn out covid-19 vaccines and medication
are once again propping the Nifty Pharma index after a brief hibernation, when
the first wave had started receding in H2 of FY 2021. The Nifty Bank index has
doubled from its year-ago bottom, coming out of correction. Provisioning and
capital collection are supposed to facilitate higher credit flow. The Nifty
Metal and Commodities indices are touching new tops due to the revival of capex
and prospect of another season of bumper harvest. They might plateau as central
banks end their loose monetary policies early 2022.  In the run-up, attention will shift to the
third orbit comprising frontline sectors including aviation and hospitality.
The leaders in the entertainment and retail space are up from their pandemic
lows and holding on to their gains. Services is consolidating the comeback of
the US, initially fronted by tech and then by manufacturing, with outdoor masks
no longer required for those inoculated with two doses. The sharp drop in
caseloads and estimates of all Indian adults getting two jabs by December 2021 are
setting the stage for funds to move into the next upcycle. 
No comments:
Post a Comment